About Fingolimod Hydrochloride
            
            Class: | Sphingosine 1-phosphate receptor modulator  
Use: | Treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the progression of disability  
Adult dose: | 0.5 mg orally once daily  
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years of age  
Side effects: | Headache, elevated liver enzymes, diarrhea, cough, back pain, fatigue, and bradycardia  
Contraindications: | History of myocardial
         
        
            
                
                
                    
                        Drug Class
                    
                    Sphingosine 1-phosphate receptor modulator
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the progression of disability
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F)
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novartis Pharma AG, SWITZERLAND
                    
                    
                    Package Size
                    28's (14's Blister x 2)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 12971.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        0.5 mg orally once daily
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients under 18 years of age
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, elevated liver enzymes, diarrhea, cough, back pain, fatigue, and bradycardia
                 
             
         
        
        
            
                Contraindications & Precautions
            
            History of myocardial infarction, unstable angina, stroke, transient ischemic attack, heart failure, or severe untreated sleep apnea; concurrent use of Class Ia or Class III antiarrhythmic drugs; hypersensitivity to fingolimod or any component of the formulation
         
        
        
            
                Important Warnings
            
            Risk of serious infections, including progressive multifocal leukoencephalopathy (PML); monitor for signs and symptoms of infection; may cause bradycardia; require monitoring of heart rate and blood pressure after the first dose; liver function tests should be performed prior to and during treatment.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.